Georg-Speyer-Haus. Foto: Andreas Reeg, andreasreeg.com Research for Life
Georg-Speyer-Haus. Foto: Andreas Reeg, andreasreeg.com
Georg-Speyer-Haus. Foto: Andreas Reeg, andreasreeg.com
Georg-Speyer-Haus. Foto: Andreas Reeg, andreasreeg.com

Diversity at the research institute

Georg-Speyer-Haus is part of Germany’s largest diversity network and is expressly committed to diversity in the work environment. With the Diversity Charter, GSH implements a variety of concepts and measures along all diversity dimensions as part of sustainable diversity management. Read more ->

Tumor-associated macrophages as therapeutic targets in brain metastases

Researcher at the Georg-Speyer-Haus and the University of Lausanne developed a novel combination therapy that prevents the acquisition of adaptive resistance and thereby results in improved efficacy in experimental brain metastasis. Read more ->

ERC Advanced Grant 2021 for PLASTICITY

Director Prof. Dr. Florian Greten again receives the highest EU science award for his colorectal cancer research and for the development of new therapeutic approaches. The project Cell Plasticity in Metastatic Colorectal Cancer – PLASTICAN will be funded with 2.5 million EUR for the next 5 years. Read more ->

Page 1 of 4.

1 2 3 4

Diversity at research institute

Appreciation and esteem in their entire scope | Frankfurt am Main, July 2021 – The private foundation Chemotherapeutic Research Institute Georg-Speyer-Haus signs the Diversity Charter and visibly commits to an appreciative and bias-free working environment. With thus GSH sends a clear signal for diversity and tolerance in professional world and expresses their appreciation for all… [mehr]

Tumor-associated macrophages in brain metastases

Tumor-associated macrophages as therapeutic targets in brain metastases Frankfurt am Main, 10/19/2021 – The Max-Eder Junior Group led by Dr. Lisa Sevenich (Georg-Speyer-Haus) demonstrated in collaboration with researchers and clinicians at the University of Lausanne and the Institute of Neurology (Edinger Institute, University Hospital Frankfurt), that TAM-targeted therapies by colony stimulating factor 1 receptor (CSF1R)… [mehr]

ERC Advanced Grant 2021 goes to Prof. Dr. Greten

Great Award for Director of the Georg-Speyer-Haus Frankfurt am Main, April 22, 2021 – The European Research Council (ERC) is funding a project by Prof. Dr. Florian R. Greten with a prestigious Advanced Grant. Prof. Greten is director of the Georg-Speyer-Haus (GSH), Institute for Tumor Biology and Experimental Therapy, and speaker of the LOEWE -… [mehr]

1st certificate for GSH HR strategy

GSH receives audit berufundfamilie certificate For the first time, Georg-Speyer-Haus received the audit berufundfamilie certificate for the strategic design of its family- and life-phase-conscious personnel policy. The certificate, that is considered a label of quality for a company compatibility policy, is awarded by the board of trustees of berufundfamilie Service GmbH under the German Federal… [mehr]

Dr. Medyouf participates in EU ITN INTERCEPT-MDS

Dr. Medyouf participates in the European Innovative Training Network INTERCEPT-MDS focusing on the shared training and research in Myeloid Diseases.   Dr. Medyouf’s team will participate in the European Innovative Training Network (ITN) INTERCEPT-MDS, a Marie Skłodowska Curie Action, funded by the European Commission under H2020 framework programme, and coordinated by Dr. Marcus Buschbeck at… [mehr]

New EU research consortium with participation of GSH

GSH generates an extensive pharmacological drug library with other institutions and pharmaceutical companies | The EUbOPEN consortium (Enabling and Unlocking Biology in the OPEN) aims to generate a comprehensive pharmacological drug library and make it accessible to the research community. The EU project of the Innovative Medicines Initiative (IMI2), which is funded for 5 years,… [mehr]

Beug Foundation Research Award for Dr. Sevenich on metastasis research

This year's 2019 Beug Foundation Metastasis Research Award goes to Dr. Lisa Sevenich for her efforts in studying T-cell responses in brain metastases. "I am very honored by this award. The grant from the Beug Foundation will allow us to study new types of aspects of the complex interactions between tumor cells and immune cells… [mehr]

Prof. Dr. Krause receives project funding from EKFS

Else Kroener-Fresenius-Foundation funds research project of Prof. Dr. Daniela Krause The main focus of the research group headed by Prof. Dr. Daniela Krause is the extracellular matrix in the bone marrow to improve normal and inhibit malignant blood formation. The funding by the EKF Foundation enables the lab unit of Prof. Dr. Krause to investigate… [mehr]

Extention DFG research group for colorectal cancer

Cell Plasticity in Colorectal Carcinogenesis research group under leadership of Prof. Dr. Greten receives extension for additional 3 years   Colorectal cancer is the second leading cause of death among cancers. Although there have been advancements in diagnosis, therapy in patients with metastases has only been successful in a few patients over the past 60… [mehr]

Page 1 of 4.

1 2 3 4